[11C]MeDAS

N/A

Report date: 2024/07/27 20:00:03
NME

Base Information

Drug Name[11C]MeDAS
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCase Western Reserve University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCase Western Reserve UniversityRobert Fox Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A